why choose us

First received: November 06, 2023

Clinical Trial: A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Myeloma

Study Type: OBSERVATIONAL


Official Title: Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD

Brief Summary: This is an observational study that will include both participants with relapsed/refractory Multiple Myeloma and their doctors.The purpose of this study is to gather information about the use of hematopoietic cell transplantation/HCT and B-cell maturation antigen /BCMS targeted chimeric antigen receptor/CAR autologous T-cell therapy.

Read more